Cargando…
Formation of gadolinium–ferritin from clinical magnetic resonance contrast agents
Gadolinium deposition in the brain following administration of gadolinium-based contrast agents (GBCAs) has led to health concerns. We show that some clinical GBCAs form Gd(3+)–ferritin nanoparticles at (sub)nanomolar concentrations of Gd(3+) under physiological conditions. We describe their structu...
Autores principales: | Neburkova, Jitka, Rulseh, Aaron M., Chang, Shery L. Y., Raabova, Helena, Vejpravova, Jana, Dracinsky, Martin, Tarabek, Jan, Kotek, Jan, Pingle, Mohan, Majer, Pavel, Vymazal, Josef, Cigler, Petr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9417687/ https://www.ncbi.nlm.nih.gov/pubmed/36133872 http://dx.doi.org/10.1039/c9na00567f |
Ejemplares similares
-
Optical imaging of localized chemical events using programmable diamond quantum nanosensors
por: Rendler, Torsten, et al.
Publicado: (2017) -
Does serial administration of gadolinium‐based contrast agents affect patient neurological and neuropsychological status? Fourteen‐year follow‐up of patients receiving more than fifty contrast administrations
por: Vymazal, Josef, et al.
Publicado: (2019) -
Whole brain apparent diffusion coefficient measurements correlate with survival in glioblastoma patients
por: Rulseh, Aaron Michael, et al.
Publicado: (2019) -
Eighteen years’ experience with tumor treating fields in the treatment of newly diagnosed glioblastoma
por: Vymazal, Josef, et al.
Publicado: (2023) -
Comparison of CT and MR imaging in ischemic stroke
por: Vymazal, Josef, et al.
Publicado: (2012)